Cases & Deals

Share

Aprea Therapeutics completes $97 million IPO

October 2019

Client(s) Aprea Therapeutics, Inc.

Jones Day served as IP counsel in connection with the $97 million initial public offering of Aprea Therapeutics, Inc. (NASDAQ: APRE). Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.